Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gerald Paul Fitzgerald"'
Publikováno v:
Expert review of cardiovascular therapy. 17(10)
Introduction: The introduction of cardiac troponin (cTn) assays have revolutionized the diagnosis and management of acute myocardial infarction in Emergency Departments worldwide. Its success has led to significant research and development investment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9f2cfafd0f9d7abf70ccc2b2c3dc48
https://pubmed.ncbi.nlm.nih.gov/31574239
https://pubmed.ncbi.nlm.nih.gov/31574239
Autor:
Gerald Paul Fitzgerald, T Kiernan
Publikováno v:
General poster abstracts 2.
Introduction Functional analysis of coronary artery stenosis is an important tool in the assessment of angiographic intermediate lesions. The deferral of treatment with percutaneous coronary intervention (PCI) of angiographic intermediate but functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0098cae2e5e79cd5604340e905b284e7
https://doi.org/10.1136/heartjnl-2018-ics.41
https://doi.org/10.1136/heartjnl-2018-ics.41
Autor:
I Ullah, Abdalla Ibrahim, Zahir Satti, C Cahill, T Kiernan, John Calvin Coffey, J Saunders, Gerald Paul Fitzgerald
Publikováno v:
General poster abstracts 2.
Introduction Acute coronary syndrome is a major cause of morbidity and mortality in the developed world. Timely intervention in ST elevation myocardial infarction is one of the major success stories of interventional cardiology. Delays in reperfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cc7c4188ebf01ca05f7eaa749f8b242
https://doi.org/10.1136/heartjnl-2018-ics.42
https://doi.org/10.1136/heartjnl-2018-ics.42
Autor:
T Kiernan, Gerald Paul Fitzgerald
Publikováno v:
Expert review of cardiovascular therapy. 16(8)
PCSK9 inhibitors are monoclonal antibodies to proprotein convertase-subtilisin/kexin type 9 which significantly reduce LDL cholesterol concentration in vivo by inhibiting degradation of the LDL receptor in hepatocytes. The introduction of PCSK9 inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af617e94d5a5baa185301fe167c91c55
https://pubmed.ncbi.nlm.nih.gov/29979908
https://pubmed.ncbi.nlm.nih.gov/29979908
A 34-year-old woman presented to our service with chest pain, a troponin rise and dynamic ECG changes. Of note, she had complained of fatigue, feeling constitutionally unwell and a generalised rash in the days prior to her presentation. Her echocardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33ca319c04f9f11c060885109e87133
https://europepmc.org/articles/PMC5747783/
https://europepmc.org/articles/PMC5747783/
Autor:
Gerald Paul Fitzgerald, David Keohane
Publikováno v:
BMJ Case Rep
This case demonstrates the effectiveness and ongoing potential of novel lung cancer therapies, specifically immunotherapy agents such as nivolumab, a T-cell programmed death 1 (PD-1) receptor inhibitor. In this case study, our patient had a significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e3dd9c8ed54c6cacda974692006cc7
https://doi.org/10.1136/bcr-2018-224784
https://doi.org/10.1136/bcr-2018-224784
Publikováno v:
BMJ Case Reports
A 23-year-old Asian student presented to our service with a 1-month history of fever, weight loss of 10 kg, night sweats, fatigue and general malaise. He was previously well with no significant medical or family history. He had a low-grade pyrexia an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c09fb3d515473a571698f62cb6a508a9
https://doi.org/10.1136/bcr-2017-223656
https://doi.org/10.1136/bcr-2017-223656